New Drugs on the Horizon: Matrix Metalloproteinase Inhibitors
Open Access
- 1 July 1999
- journal article
- special feature
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 17 (4) , 237-240
- https://doi.org/10.1002/stem.170237
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteersBritish Journal of Clinical Pharmacology, 1998
- Changing views of the role of matrix metalloproteinases in metastasisJNCI Journal of the National Cancer Institute, 1997
- Matrix Metalloproteinase Inhibition as a Novel Anticancer Strategy: A Review with Special Focus on Batimastat and MarimastatPharmacology & Therapeutics, 1997
- Complex Roles of Matrix Metalloproteinases in Tumor ProgressionPublished by Springer Nature ,1996